WEBINAR
Share:

Design Changes After Clearance: When a New 510(k) Is Required

  • Date
    21 August 2026
  • 11.00 AM Eastern Time (US/Canada)
    03.00 PM GMT

Course is now LIVE. Click below to join the session.

This course strengthens the ability to evaluate post-clearance device changes consistently, determine when existing clearance remains supportable, and document the regulatory rationale behind decisions to submit or not submit a new 510(k).

/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }
REGISTRATION OPTIONS

Live session Plus
Complimentary 30 Days Streaming access

$290  |  One participant (viewer)

$390  |  Team (2 - 5 participants)

$490 |  Team (6 - 10 participants)

REGISTER FOR THE COURSE

US $290 per learner

30-Days Unlimited Streaming Access

/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }

REGISTER FOR THE COURSE

To Get 30-Day Access to ONLY this Course 

US $290 per learner
  • This course is Included in Subscription Pack
Subscription include access to entire Learning Library
/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }
  • Faculty
    TalkFDA Expert
  • Duration
    90 Minutes
  • Course ID
    TF3756
  • Live Q&A +
    Post-live Continued Learning
  • Presentation Handout
    & Templates
  • Assessment
    & Certification Included

 

Why take this course?

Changes to a 510(k)-cleared medical device can arise from design improvements, component substitutions, labeling revisions, manufacturing changes, software updates, risk controls, or responses to field experience. Each change requires an assessment of whether it could significantly affect the device’s safety or effectiveness, or whether it represents a major change or modification in intended use. The decision determines whether the change can proceed under the existing clearance or requires submission and clearance of a new 510(k).


This course focuses on the practical evaluation of post-clearance device changes using FDA’s risk-based approach to 510(k) change assessment. It addresses how intended use, labeling, technology, performance, materials, manufacturing, and software-related changes influence the submission decision; how multiple related changes should be considered together; and how risk analysis and supporting testing inform the conclusion. Particular attention is given to documenting decisions when a new 510(k) is determined not to be required.

Make Better 510(k) Decisions Before Implementing Device Changes

Develop a structured basis for assessing whether changes to intended use, labeling, technology, materials, manufacturing, performance, or software could cross the threshold for a new 510(k). This helps regulatory, quality, and engineering teams reach consistent conclusions before implementation rather than attempting to justify the regulatory pathway after changes have already occurred.

Strengthen the Evidence Behind No-New-510(k) Conclusions

Learn how risk assessment, testing, design-control evidence, and documented reasoning support decisions that a modification can remain under an existing clearance. When several changes accumulate or interact, a clear assessment of their collective impact becomes particularly important for demonstrating why the marketed device remains appropriately covered by its existing 510(k).

Key Areas Covered

  • FDA decision principles for determining when a device modification requires a new 510(k)
  • Evaluating changes to intended use, indications, labeling, and conditions of use
  • Assessing technology, engineering, materials, performance, and manufacturing modifications
  • Determining the regulatory impact of software and firmware changes
  • Applying risk-based assessment to changes that may affect device safety or effectiveness
  • Evaluating multiple related or cumulative modifications rather than treating each change in isolation
  • Using testing, risk analysis, and design-control evidence to support the submission decision
  • Documenting the rationale when a new 510(k) is determined not to be required

Who Must Attend

  • Regulatory Affairs Departments
  • Quality Assurance Departments
  • Design Engineering
  • Product Development / R&D Departments
  • Design Quality / Quality Engineering
  • Regulatory Compliance Departments
  • Risk Management
  • Software / Firmware Engineering
  • Manufacturing Engineering
  • Medical Device Quality Systems
Meredith Crabtree
COURSE DIRECTOR

Meredith Crabtree

Meredith Crabtree has over 30 years of experience across regulated laboratory, pharmaceutical, manufacturing, packaging, labeling, and distribution operations. Her work in regulatory assessments, third-party inspections, consent decree support, recall support, and quality training provides relevant perspective on analytical oversight, documentation quality, lifecycle decisions, and inspection-facing compliance expectations across regulated operations. 

If you would like to request a Proforma invoice to sign up for this course. please click here

Commonly Asked Questions About This Subject

The following questions address practical regulatory, compliance, validation, quality, operational, and inspection-related considerations commonly associated with this subject.

How much development knowledge should be retained after an analytical method has been validated? 

Validation data alone is rarely enough to support future lifecycle decisions. The documentation that becomes valuable years later is often the scientific reasoning developed while the method was being designed. During inspections, reviewers may ask why a parameter was selected, why an alternative approach was rejected, or what evidence supports the method's operating range. Those answers are difficult to reconstruct if development knowledge was discarded once validation was complete. 


Documentation carrying the greatest value explains how critical method variables were identified, what studies established method robustness, what limitations were recognized, and where acceptable flexibility exists. That information becomes essential when laboratories investigate unexpected performance, transfer methods to another site, evaluate equipment changes, or justify modifications. Retaining development knowledge allows later decisions to be based on documented scientific understanding rather than assumptions made years after the original work was completed.

When does an analytical method change require more than routine change control? 

The decision depends on whether the change alters the scientific basis on which the method was shown to perform reliably. Small procedural adjustments may appear administrative, yet they sometimes influence selectivity, precision, sensitivity, robustness, or interpretation of results in ways that are not immediately obvious. 


Inspection concerns frequently arise when organizations classify changes according to their apparent size instead of evaluating their potential impact on method performance. A revised column, software update, reagent source, sample preparation step, or instrument platform may appear minor individually, but together they can significantly alter method behavior. 


Documentation becomes more defensible when each proposed change includes a technical assessment explaining why existing validation evidence remains applicable or why additional studies are necessary. The strength of that justification generally carries more weight than the classification assigned during change control. 

How should laboratories determine whether changing method performance represents normal variability or meaningful analytical drift? 

A practical decision begins with understanding how the method has behaved over time rather than evaluating a single event in isolation. Individual outliers rarely provide enough information to establish analytical drift. Gradual changes across multiple runs, analysts, instruments, or laboratories often provide stronger evidence that performance is evolving. 


Inspection discussions commonly focus on situations where each event received an acceptable explanation, yet the broader pattern remained unevaluated. Increasing system suitability variability, recurring adjustments, shifting recoveries, or steadily changing precision may each appear acceptable independently while collectively indicating declining method capability. 


Evidence supporting sound lifecycle management includes long-term performance trending, comparison with historical baselines, documented technical assessment, and evaluation of whether observed changes remain consistent with the method's intended operating characteristics. Looking across the full performance history generally provides a stronger scientific basis than reviewing isolated data points.

What separates a successful analytical method transfer from one that creates repeated investigations after implementation? 

A successful transfer demonstrates that receiving laboratories understand the method rather than simply reproducing expected results during transfer activities. Methods often perform well under controlled transfer protocols yet generate recurring deviations once routine testing begins because important operational knowledge was never transferred. 


Inspection friction develops when analysts receive procedures without understanding method sensitivities, known limitations, acceptable adjustments, common failure modes, or historical performance characteristics. Those gaps frequently lead to avoidable investigations and inconsistent execution despite technically successful transfer documentation. 


Evidence carrying substantial weight includes documented knowledge transfer, evaluation of laboratory-specific variables, assessment of equipment differences, analyst readiness, and confirmation that routine operating conditions remain consistent with the method's validated intent. Effective transfers establish long-term method reliability rather than focusing exclusively on completion of transfer acceptance criteria. 

Your TalkFDA Webinar Experience

When you reserve your seat, everything is organized for you — from access to certification from one place.

1. Confirmation

You receive a confirmation email and your course appears instantly in your TalkFDA dashboard.

2. Your Course Hub
Your TalkFDA course page becomes your central hub where you can join the session, access materials, and manage your learning.

3. Join the Live Training
At the scheduled time, click Join Session and you’ll be connected to the live Webex session with the instructor.

4. Watch Again Anytime
After the session, the playback becomes available on the same course page so you can revisit important sections.
5. Earn Your Certificate
Complete the course and your certificate is unlocked automatically in your learning history.

Everything related to your webinar: access, materials, playback, and certification — lives in one place.
Simple. Organized. Professional.
Go ahead and reserve your seat with confidence.

Built on 20+ years of global regulatory training experience across FDA, EMA, MHRA, and ICH frameworks.
Trusted by professionals across 80+ countries.

Testimonials

This is an upcoming session. Feedback below reflects experiences from similar programs delivered by our expert faculty.

“Session was easy to follow even for non-core team members. That helped.”
- Production Officer
“Good balance. Not too basic, not too deep. Worked well for mixed team.”
- Manager, Regulatory Affairs
“Team found it useful. Especially for aligning understanding across functions.”
- Director, Operations

Ready to Strengthen Your Team? Let’s Build Your Training Plan.

Whether you’re looking for a single onsite workshop or a multi-team training series, we’ll help you design a program that fits your goals, timelines, and operational reality.

Your team deserves the clarity.
Your organization deserves the confidence.

Upcoming Courses

Featured Courses